Diagnosis and Treatment of Type 1 Diabetes Mellitus in Pediatrics: A Comprehensive Approach

• Autor(a) principal: Braga e Silva, Ana Luíza
• Data de Publicação: 2023
• Outros Autores: Amaral Moreira , Renata, Fabrício de Araújo Coelho, Mariana, de Souza Oliveira , Paloma Maria, Ribeiro Santiago Ferreira , João Pedro
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Brazilian Journal of Implantology and Health Sciences
• Texto Completo: https://bjihs.emnuvens.com.br/bjihs/article/view/1013
• topic: Diabetes Mellitus Tipo 1; Pediatria; Monitoramento Contínuo.; Type 1 Diabetes Mellitus; Pediatrics; Continuous Monitoring.

Significant advances in the diagnosis and treatment of Type 1 Diabetes Mellitus (T1DM) in pediatric patients represent pivotal milestones in the professional realm, providing a comprehensive view of emerging therapeutic approaches. Among the discussed strategies, the crucial role of pancreas transplantation, as evidenced by recent studies, stands out. The success of this procedure in highly selected cases offers an optimistic outlook, albeit with the caveat that it should be considered as a last resort, administered in specialized centers, reinforcing the need for a judicious approach. Additionally, the effectiveness of technological innovations such as closed-loop therapy systems, analog insulins, and automatic infusion devices is examined. Positive outcomes from these interventions indicate a significant shift in the management of T1DM in children, with substantial improvements in glycemic control and quality of life. However, the critical analysis of studies underscores the importance of considering the specific nuances of the pediatric age group in the development of therapeutic strategies. Relevant aspects related to cutaneous reactions associated with the use of devices such as insulin pumps and glucose monitors are of paramount importance in the multidisciplinary context. By identifying the prevalence of these reactions and their implications, the urgent need for guidelines for the prevention and management of these cutaneous issues in children with T1DM is emphasized. A multidisciplinary approach, involving diabetologists, dermatologists, and other healthcare professionals, emerges as essential to ensure enhanced cutaneous tolerability and, consequently, the long-term effectiveness of treatment for this pediatric population. Finally, the continuous importance of research and innovation in building a promising future for children facing the complexity of T1DM is underscored. The personalized approach to early diagnosis, coupled with therapeutic interventions tailored to individual needs, promotes not only clinical advancements but also a compassionate approach in managing this chronic condition in pediatric patients. The study concludes by emphasizing the ongoing need for collaboration among healthcare professionals, researchers, and the industry to drive significant advances in the field of diagnosis and treatment of T1DM in Pediatrics.